EVP, Chief Legal Officer van der Vaart Sandra D of Laboratory Corp of America Holdings (LH, Financial) has sold 3,553 shares of the company on March 28, 2024, according to a recent SEC filing. The transaction was executed at an average price of $216.74 per share, resulting in a total sale amount of $770,261.22.
Laboratory Corp of America Holdings, commonly known as LabCorp, is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. LabCorp operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. The company provides diagnostic, drug development, and technology-enabled solutions for more than 160 million patient encounters per year.
Over the past year, the insider has sold a total of 4,454 shares of Laboratory Corp of America Holdings (LH, Financial) and has not made any purchase of the company's shares. This latest transaction continues the trend observed over the past year, where there have been no insider buys and 11 insider sells.
On the date of the insider's recent sale, shares of Laboratory Corp of America Holdings (LH, Financial) were trading at $216.74, giving the company a market capitalization of $18.37 billion. The stock's price-earnings ratio stands at 46.98, which is above the industry median of 31.73 and also higher than the company's historical median price-earnings ratio.
According to the GuruFocus Value chart, with a stock price of $216.74 and a GuruFocus Value of $225.15, Laboratory Corp of America Holdings (LH, Financial) has a price-to-GF-Value ratio of 0.96, indicating that the stock is Fairly Valued in relation to its intrinsic value.
The GF Value is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's past returns and growth, and future business performance estimates from Morningstar analysts.
The insider transaction history and the current valuation metrics provide investors with context for the recent insider sale. While the price-to-GF-Value ratio suggests that the stock is fairly valued, investors often consider insider selling activity when analyzing a stock's potential future performance.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
